US2023371850A1PendingUtilityA1

System and method for mode switching

Assignee: DEXCOM INCPriority: Sep 22, 2014Filed: Jul 21, 2023Published: Nov 23, 2023
Est. expirySep 22, 2034(~8.2 yrs left)· nominal 20-yr term from priority
A61B 5/14532A61B 5/1455A61B 5/1486A61B 5/746A61B 5/7282A61B 5/7221A61M 5/1723A61B 5/742A61B 5/7475A61B 5/14503A61B 5/7435A61B 5/1495G16H 40/63G16H 40/40A61B 5/14546A61B 5/0002A61B 5/7275A61B 2560/0223A61M 2230/005A61M 2230/201A61B 2560/0487A61B 5/72A61B 5/6898A61B 5/0004Y02A90/10
84
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Systems and methods described provide dynamic and intelligent ways to change the required level of user interaction during use of a monitoring device. The systems and methods generally relate to real time switching between a first or initial mode of user interaction and a second or new mode of user interaction. In some cases, the switching will be automatic and transparent to the user, and in other cases user notification may occur. The mode switching generally affects the user's interaction with the device, and not just internal processing. The mode switching may relate to calibration modes, data transmission modes, control modes, or the like.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A computer-implemented method comprising:
 receiving glucose values of a user from a glucose sensor of an artificial pancreas system worn by the user, the artificial pancreas system including the glucose sensor and an insulin delivery pump;   determining an accuracy or reliability of the glucose values received from the glucose sensor, the accuracy or reliability of the glucose values based at least in part on a number of consecutive glucose values received from the glucose sensor;   responsive to determining that the accuracy or reliability of the glucose sensor is above a threshold, controlling the artificial pancreas system to operate in a therapeutic mode by controlling the insulin delivery pump to automatically administer insulin to the user based on the glucose values; and   responsive to determining that the accuracy or reliability of the glucose sensor is below the threshold, transitioning the artificial pancreas system directly from the therapeutic mode to an adjunctive mode.   
     
     
         2 . The computer-implemented method of  claim 1 , wherein the threshold comprises a threshold number of consecutive glucose values received from the glucose sensor. 
     
     
         3 . The computer-implemented method of  claim 2 , wherein the determining the accuracy or reliability of the glucose values received from the glucose sensor further comprises determining whether the number of consecutive glucose values received from the glucose sensor is at least equal to the threshold number of consecutive glucose values. 
     
     
         4 . The computer-implemented method of  claim 3 ,
 wherein the artificial pancreas system is configured to operate in the therapeutic mode if the number of consecutive glucose values received from the glucose sensor is at least equal to the threshold number of consecutive glucose values, and   wherein the artificial pancreas system is controlled to transition to the adjunctive mode if the number of consecutive glucose values received from the glucose sensor is below the threshold number of consecutive glucose values.   
     
     
         5 . The computer-implemented method of  claim 2 , wherein the threshold number of consecutive glucose values received from the glucose sensor comprises three consecutive glucose values received from the glucose sensor. 
     
     
         6 . The computer-implemented method of  claim 2 , wherein the threshold number of consecutive glucose values received from the glucose sensor comprises two consecutive glucose values received from the glucose sensor. 
     
     
         7 . The computer-implemented method of  claim 1 , wherein the glucose values are received from the glucose sensor at a predetermined interval. 
     
     
         8 . The computer-implemented method of  claim 7 , wherein the predetermined interval comprises 5 minutes. 
     
     
         9 . The computer-implemented method of  claim 1 , wherein the artificial pancreas system is configured to operate in a closed loop while in the therapeutic mode. 
     
     
         10 . An artificial pancreas system comprising:
 a glucose sensor;   an insulin delivery pump; and   a computing device comprising at least a memory and a processor to perform operations comprising:
 receiving glucose values of a user from the glucose sensor of the artificial pancreas system; 
 determining an accuracy or reliability of the glucose values received from the glucose sensor, the accuracy or reliability of the glucose values based at least in part on a number of consecutive glucose values received from the glucose sensor; 
 responsive to determining that the accuracy or reliability of the glucose sensor is above a threshold, controlling the artificial pancreas system to operate in a therapeutic mode by controlling the insulin delivery pump to automatically administer insulin to the user based on the glucose values; and 
 responsive to determining that the accuracy or reliability of the glucose sensor is below the threshold, transitioning the artificial pancreas system directly from the therapeutic mode to an adjunctive mode. 
   
     
     
         11 . The artificial pancreas system of  claim 10 , wherein the threshold comprises a threshold number of consecutive glucose values received from the glucose sensor. 
     
     
         12 . The artificial pancreas system of  claim 11 , wherein the determining the accuracy or reliability of the glucose values received from the glucose sensor further comprises determining whether the number of consecutive glucose values received from the glucose sensor is at least equal to the threshold number of consecutive glucose values. 
     
     
         13 . The artificial pancreas system of  claim 12 ,
 wherein the artificial pancreas system is configured to operate in the therapeutic mode if the number of consecutive glucose values received from the glucose sensor is at least equal to the threshold number of consecutive glucose values, and   wherein the artificial pancreas system is controlled to transition to the adjunctive mode if the number of consecutive glucose values received from the glucose sensor is below the threshold number of consecutive glucose values.   
     
     
         14 . The artificial pancreas system of  claim 11 , wherein the threshold number of consecutive glucose values received from the glucose sensor comprises three consecutive glucose values received from the glucose sensor. 
     
     
         15 . The artificial pancreas system of  claim 11 , wherein the threshold number of consecutive glucose values received from the glucose sensor comprises two consecutive glucose values received from the glucose sensor. 
     
     
         16 . The artificial pancreas system of  claim 10 , wherein the glucose values are received from the glucose sensor at a predetermined interval. 
     
     
         17 . The artificial pancreas system of  claim 16 , wherein the predetermined interval comprises 5 minutes. 
     
     
         18 . The artificial pancreas system of  claim 10 , wherein the artificial pancreas system is configured to operate in a closed loop while in the therapeutic mode. 
     
     
         19 . One or more computer-readable storage media comprising instructions stored thereon that, responsive to execution by one or more processors, perform operations comprising:
 receiving glucose values of a user from a glucose sensor of an artificial pancreas system worn by the user, the artificial pancreas system including the glucose sensor and an insulin delivery pump;   determining an accuracy or reliability of the glucose values received from the glucose sensor, the accuracy or reliability of the glucose values based at least in part on a number of consecutive glucose values received from the glucose sensor;   responsive to determining that the accuracy or reliability of the glucose sensor is above a threshold, controlling the artificial pancreas system to operate in a therapeutic mode by controlling the insulin delivery pump to automatically administer insulin to the user based on the glucose values; and   responsive to determining that the accuracy or reliability of the glucose sensor is below the threshold, transitioning the artificial pancreas system directly from the therapeutic mode to an adjunctive mode.   
     
     
         20 . The one or more computer-readable storage media of  claim 19 , wherein the threshold comprises a threshold number of consecutive glucose values received from the glucose sensor, and wherein determining the accuracy or reliability of the glucose values received from the glucose sensor further comprises determining whether the number of consecutive glucose values received from the glucose sensor is at least equal to the threshold number of consecutive glucose values.

Join the waitlist — get patent alerts

Track US2023371850A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.